Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters











Database
Language
Publication year range
1.
Sci Rep ; 13(1): 20521, 2023 11 22.
Article in English | MEDLINE | ID: mdl-37993612

ABSTRACT

Through extensive multisystem phenotyping, the central aim of Project PICMAN is to correlate metabolic flexibility to measures of cardiometabolic health, including myocardial diastolic dysfunction, coronary and cerebral atherosclerosis, body fat distribution and severity of non-alcoholic fatty liver disease. This cohort will form the basis of larger interventional trials targeting metabolic inflexibility in the prevention of cardiovascular disease. Participants aged 21-72 years with no prior manifest atherosclerotic cardiovascular disease (ASCVD) are being recruited from a preventive cardiology clinic and an existing cohort of non-alcoholic fatty liver disease (NAFLD) in an academic medical centre. A total of 120 patients will be recruited in the pilot phase of this study and followed up for 5 years. Those with 10-year ASCVD risk ≥ 5% as per the QRISK3 calculator are eligible. Those with established diabetes mellitus are excluded. Participants recruited undergo a detailed assessment of health behaviours and physical measurements. Participants also undergo a series of multimodality clinical phenotyping comprising cardiac tests, vascular assessments, metabolic tests, liver and neurovascular testing. Blood samples are also being collected and banked for plasma biomarkers, 'multi-omics analyses' and for generation of induced pluripotent stem cells (iPSC). Extensive evidence points to metabolic dysregulation as an early precursor of cardiovascular disease, particularly in Asia. We hypothesise that quantifiable metabolic inflexibility may be representative of an individual in his/her silent, but high-risk progression towards insulin resistance, diabetes and cardiovascular disease. The platform for interdisciplinary cardiovascular-metabolic-neurovascular diseases (PICMAN) is a pilot, prospective, multi-ethnic cohort study.


Subject(s)
Atherosclerosis , Cardiovascular Diseases , Cardiovascular System , Non-alcoholic Fatty Liver Disease , Humans , Male , Female , Cohort Studies , Prospective Studies , Risk Factors
2.
Dev Biol ; 458(1): 98-105, 2020 02 01.
Article in English | MEDLINE | ID: mdl-31682806

ABSTRACT

Attempts to constitutively knockout HTT in rodents resulted in embryonic lethality, curtailing efforts to study HTT function later in development. Here we show that HTT is dispensable for early zebrafish development, contrasting published zebrafish morpholino experiment results. Homozygous HTT knockouts were embryonically viable and appeared developmentally normal through juvenile stages. Comparison of adult fish revealed significant reduction in body size and fitness in knockouts compared to hemizygotes and wildtype fish, indicating an important role for wildtype HTT in postnatal development. Our zebrafish model provides an opportunity to understand the function of wildtype HTT later in development.


Subject(s)
Models, Animal , Nerve Tissue Proteins/physiology , Zebrafish Proteins/physiology , Zebrafish/genetics , Amino Acid Sequence , Animals , Body Size , CRISPR-Cas Systems , Conserved Sequence , Embryo, Nonmammalian/drug effects , Embryo, Nonmammalian/embryology , Gene Editing , Gene Knockout Techniques , Genetic Association Studies , Genetic Fitness , Humans , Huntingtin Protein/chemistry , Morpholinos/pharmacology , Nerve Tissue Proteins/deficiency , Nerve Tissue Proteins/genetics , Neurulation/genetics , Sequence Alignment , Sequence Homology, Amino Acid , Zebrafish/embryology , Zebrafish/growth & development , Zebrafish Proteins/deficiency , Zebrafish Proteins/genetics
SELECTION OF CITATIONS
SEARCH DETAIL